OctoPlus publishes prospectus for listing of shares issued on 18 December 2009
Click here to go to the webcast of OctoPlus' half-year results on Thursday 6 August at 10 AM CET
Click here to directly access OctoPlus' Annual Report 2008
OctoPlus has increased its fill & finish capacity by expanding its GMP facility
General information about OctoPlus' history, location, capabilities and activities
A novel dextran-based microsphere delivery technology for proteins and particulate systems
A biodegradable polymeric drug delivery system for the controlled release of proteins and lipophilic small molecules
A biodegradable polymeric drug delivery system for peptides and small molecules
General information about OctoPlus' formulation development expertise, liposome formulation and analytical support
In-depth information about formulation development for poorly water-soluble drug compounds, liposomes and analytical support
In-depth information about formulation development with special excipients for pulmonary delivered drug compounds
Factsheet on our capacities for formulation, manufacturing and freezedrying of clinical study material and small scale commercial material
